Quinazoline derivatives of formula (I); for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to process for their preparation, as well as pharmaceutical compositions containing them as active ingredient. ##STR00001##
Claims What we claim is: 1. A compound of formula (I) ##STR00061## or a salt, ester or prodrug thereof; where: X is O or NR.sup.6; R.sup.6 is hydrogen or C.sub.1-4alkyl; R.sup.1 is hydrogen, halo, or --X.sup.1R.sup.11; X.sup.1 is a direct bond, --CH.sub.2.dbd.CH.sub.2--, --O--, --NH--, --N(C.sub.1-6alkyl)-, --C(O)O--, --C(O)O--, --OC(O)O--, --NHC(O)--, --N(C.sub.1-6alkyl)C(O)--, --C(O)NH-- or --C(O)N(C.sub.1-6alkyl)-; R.sup.11 is hydrogen, or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by 1 or 2 substituents independently selected from halo, hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, --NR.sup.9R.sup.10, --C(O)R.sup.9, --C(O)NR.sup.9R.sup.10 and --C(O)OR.sup.9; R.sup.2 is hydrogen, halo, nitro, cyano or --X.sup.2R.sup.12; X.sup.2 is a direct bond, --O--, --NH--, --N(C.sub.1-6alkyl)-, --OC(O)-- or --C(O)O--; R.sup.12 is hydrogen, or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl, which group is optionally substituted by 1, 2 or 3 substituents selected from halo, hydroxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, --NR.sup.15R.sup.16, --NHC(O)NR.sup.15R.sup.16, --C(O)R.sup.15 and --C(O)OR.sup.15; R.sup.3 is hydrogen, halo or --X.sup.3R.sup.13; X.sup.3 is a direct bond, --CH.sub.2.dbd.CH.sub.2--, --O--, --NH--,--N(C.sub.1-6alkyl)-, --C(O)--, --C(O)O--, --OC(O)--, --NHC(O)O--, --N(C.sub.1-6alkyl)C(O)--, --C(O)NH-- or --C(O)N(C.sub.1-6alkyl)-; R.sup.13 is hydrogen or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by 1 or 2 substituents independently selected from --NR.sup.7R.sup.8, --C(O)NR.sup.7R.sup.8, halo, hydroxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; R.sup.7 and R.sup.8 are independently selected from hydrogen, heterocyclyl, heterocyclylC.sub.1-4alkyl, C.sub.1-4alkylheterocyclylC.sub.1-4alkyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, C.sub.1-4alkoxyC.sub.1-6alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.3-6cycloalkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkyl, hydroxyC.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkylC.sub.1-4alkyl, haloC.sub.1-6alkyl, haloC.sub.3-6cycloalkyl, haloC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, cyanoC.sub.1-4alkyl, aminoC.sub.1-6alkyl, C.sub.1-4alkylaminoC.sub.1-6alkyl, bis(C.sub.1-4alkyl)aminoC.sub.1-6alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; or R.sup.7 and R.sup.8 together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of which one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; R.sup.4 is selected from hydrogen, halo or --X.sup.4R.sup.14; X.sup.4 is a direct bond, --O--, --NH-- or --N(C.sub.1-6alkyl)-; R.sup.14 is selected from hydrogen, C.sub.1-6alkyl, C.sub.2-6alkenyl and C.sub.2-6alkynyl; R.sup.5 is aryl or heteroaryl optionally substituted by 1, 2 or 3 substituents independently selected from halo, hydroxy, cyano, nitro, amino, C.sub.1-4alkylamino, bis(C.sub.1-4alkyl)amino, C.sub.1-4alkyl, C.sub.2-4alkenyl, C.sub.2-4alkynyl, C.sub.1-4alkoxy, --CONHR.sup.17, --NHCOR.sup.18--SR.sup.17, --S(O)R.sup.17 and --S(O)OR.sup.17; R.sup.9, R.sup.10, R.sup.15 and R.sup.16 are independently selected from hydrogen, C.sub.1-6alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.1-6alkyl, haloC.sub.1-6alkyl, aminoC.sub.1-6alkyl, C.sub.1-4alkylaminoC.sub.1-6alkyl and bis(C.sub.1-4alkyl)aminoC.sub.1-6alkyl; or R.sup.9 and R.sup.10 together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of which one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; R.sup.17 and R.sup.18 are independently selected from hydrogen, C.sub.1-4alkyl, C.sub.3-6cycloalkyl, C.sub.2-4alkenyl and C.sub.2-4alkynyl; R.sup.19 is hydrogen, hydroxyC.sub.1-4alkyl, --C(O)R.sup.20, --C(O)OR.sup.20, --CONR.sup.20R.sup.21, --NHC(O)R.sup.20 or --NHC(O)OR.sup.20; R.sup.20 are R.sup.21 are independently selected from hydrogen, C.sub.1-4alkyl and aryl. 2. A compound of formula (IA) ##STR00062## or salt or ester thereof where X, X.sup.1, X.sup.2, X.sup.3, R.sup.4, R.sup.5 and R.sup.19 are as defined in relation to formula (I) and R.sup.1' is hydrogen, halo, or --X.sup.1R.sup.11'; R.sup.11' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by a substituent selected from halo, hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, --NR.sup.9'R.sup.10', --C(O)R.sup.9', --C(O)NR.sup.9'R.sup.10' and --C(O)OR.sup.9'; R.sup.2' is hydrogen, halo, nitro, cyano or --X.sup.2R.sup.12'; R.sup.12' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl, which group is optionally substituted by 1, 2 or 3 substituents selected from halo, hydroxy, phosphonooxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, --NR.sup.15'R.sup.16', --NHC(O)NR.sup.15'R.sup.16'--, --C(O)R.sup.15'-- and --C(O)OR.sup.15'--; R.sup.3' is hydrogen, halo or --X.sup.3R.sup.13'; R.sup.13' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by 1 or 2 substituents independently selected from --NR.sup.7'R.sup.8', --C(O)NR.sup.7'R.sup.8', halo, hydroxy, phosphonooxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosponooxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; R.sup.7' and R.sup.8' are independently selected from hydrogen, heterocyclyl, heterocyclylC.sub.1-4alkyl, C.sub.1-4alkylheterocyclylC.sub.1-4alkyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, phosphonooxyC.sub.1-6alkyl, C.sub.1-4alkoxyC.sub.1-6alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.3-6cycloalkyl, phosphonooxyC.sub.3-6cycloalkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkyl, phosphonooxyC.sub.1-4alkylC.sub.3-6cycloalkyl, hydroxyC.sub.3-6cycloalkylC.sub.1-4alkyl, phosphonooxyC.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkylC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkylC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkylC.sub.1-4alkyl, haloC.sub.1-6alkyl, haloC.sub.3-6cycloalkyl, haloC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, cyanoC.sub.1-4alkyl, aminoC.sub.1-6alkyl, C.sub.1-4alkylaminoC.sub.1-6alkyl, bis(C.sub.1-4alkyl)aminoC.sub.1-6alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; or R.sup.7' and R.sup.8' together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; R.sup.9', R.sup.10', R.sup.15' and R.sup.16' are independently selected from hydrogen, C.sub.1-alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-3alkyl, hydroxyC.sub.1-6alkyl, phosphonooxyC.sub.1-6alkyl, haloC.sub.1-6alkyl, aminoC.sub.1-6alkyl, C.sub.1-6alkylaminoC.sub.1-6alkyl and bis(C.sub.1-6alkyl)aminoC.sub.1-6alkyl; or R.sup.9' and R.sup.10' together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of which one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; provided that a compound of formula (IA) contains at least one phosphonooxy group. 3. A compound or a salt or ester thereof according to claim 2 containing only one phosphonooxy group. 4. A compound or a salt or ester thereof according to claim 1 wherein R.sup.1 is hydrogen, halo or --OR.sup.11 and R.sup.11 is hydrogen or a group selected from C.sub.1-6alkyl, heterocyclyl and heterocyclylC.sub.1-4alkyl, which group is optionally substituted by a substituent selected from hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl. 5. A compound or a salt or ester thereof according to claim 1 wherein R.sup.2 is hydrogen, halo, --OR.sup.12 or --OC(O)R.sup.12 and R.sup.12 is hydrogen or a group selected from C.sub.1-4alkyl, aryl, heterocyclyl and heterocyclylC.sub.1-4alkyl which group is optionally substituted by a substituent selected from C.sub.1-4alkyl and C.sub.1-4alkoxy. 6. A compound or a salt or ester thereof according to claim 1 wherein R.sup.3 is hydrogen or --X.sup.3R.sup.13 and R.sup.13 is hydrogen, methyl, ethyl, propyl, heterocyclyl, heterocyclylmethyl, heterocyclylethyl or heterocyclylpropyl which methyl, ethyl or propyl are optionally substituted by --NR.sup.7R.sup.8, --C(O)NR.sup.7R.sup.8 or 1 or 2 halo, hydroxy or C.sub.1-4alkoxy substituents and which heterocyclylmethyl, heterocyclylethyl or heterocyclylpropyl are optionally substituted on heterocyclyl by hydroxy, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl or hydroxyC.sub.1-4alkylcarbonyl. 7. A compound or a salt or ester thereof according to claim 6 wherein R.sup.7 and R.sup.8 are independently selected from hydrogen, heterocyclyl, heterocyclylC.sub.1-4alkyl, C.sub.1-4alkylheterocyclylC.sub.1-4alkyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.3-6cycloalkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkyl, haloC.sub.1-6alkyl, C.sub.2-4alkenyl, C.sub.2-4alkynyl, cyanoC.sub.1-4alkyl, aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkyl, bis(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl and hydroxyC.sub.1-4alkylcarbonyl; or R.sup.7 and R.sup.8 together with the nitrogen to which they are attached form a heterocyclic ring selected from azetidine, pyrrolidine, piperidine, morpholine, piperazine, diazepane, 1,4-diazepane and azabicyclo[3.1.0]hexane which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, hydroxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkylcarbonyl and hydroxyC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--. 8. A compound or a salt or ester thereof according to claim 2 wherein R.sup.1' is hydrogen, halo or --OR.sup.11' and R.sup.11' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, heterocyclyl and heterocyclylC.sub.1-4alkyl, which group is optionally substituted by a substituent selected from hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, hydroxyC.sub.1 4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl. 9. A compound or a salt or ester thereof according to claim 2 wherein R.sup.2' is hydrogen, halo, --OR.sup.12' or --OC(O)R.sup.12' and R.sup.12' is hydrogen, phosphonooxy or a group selected from C.sub.1-4alkyl, aryl, heterocyclyl and heterocyclylC.sub.1-4alkyl which group is optionally substituted by a substituent selected from C.sub.1-4alkyl and C.sub.1-4alkoxy. 10. A compound or a salt or ester thereof according to claim 2 wherein R.sup.3' is hydrogen, phosphonooxy or --X.sup.3R.sup.13' and R.sup.13' is hydrogen or a group selected from C.sub.1-6alkyl, aryl, arylC.sub.1-4alkyl, heterocyclyl and heterocyclylC.sub.1-4alkyl, which group is optionally substituted by 1 or 2 substituents independently selected from --NR.sup.7'R.sup.8', --C(O)NR.sup.7'R.sup.8', halo, hydroxy, phosphonooxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl and C.sub.1-4alkylcarbonyl. 11. A compound or a salt or ester thereof according to claim 10 wherein R.sup.7' and R.sup.8' are independently selected from hydrogen, heterocyclyl, heterocyclylC.sub.1-4alkyl, C.sub.1-4alkylheterocyclylC.sub.1-4alkyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, phosphonooxyC.sub.1-6alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.3-6cycloalkyl, phosphonooxyC.sub.3-6cycloalkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkyl, phosphonooxyC.sub.1-4alkylC.sub.3-6cycloalkyl, haloC.sub.1-6alkyl, C.sub.2-4alkenyl, C.sub.2-4alkynyl, cyanoC.sub.1-4alkyl, aminoC.sub.1-4alkyl, bis(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl and phosphonooxyC.sub.1-4alkylcarbonyl; or R.sup.7' and R.sup.8' together with the nitrogen to which they are attached form a heterocyclic ring selected from azetidine, pyrrolidine, piperidine, morpholine, piperazine, diazepane, 1,4-diazepane and azabicyclo[3.1.0]hexane which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, phosphonooxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkylcarbonyl, hydroxyC.sub.1-4alkylcarbonyl and phosphonooxyC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--. 12. A compounds or a salt or ester thereof according to claim 1 wherein X is NH. 13. A compound or a salt or ester thereof according to claim 1 wherein R.sup.4 is hydrogen. 14. A compound or a salt or ester thereof according to claim 1 wherein R.sup.5 is aryl optionally substituted by 1 or 2 halo. 15. A compound or a salt or ester thereof according to claim 1 wherein R.sup.19 is hydrogen, hydroxycarbonyl, ethoxycarbonyl, aminocarbonyl and acetylamino. 16. A compound of formula (I) selected from: 2-(4-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-y- l)-N-(3-fluorophenyl)acetamide; 2-(4-{[7-(3-chloropropoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(2,3-- difluorophenyl)acetamide; 2-(4-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-y- l)-N-(2,3-difluorophenyl)acetamide; 2-(4-{[7-(3-chloropropoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(3-fl- uorophenyl)acetamide; 2-(4-{[7-(2-chloroethoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(2,3-d- ifluorophenyl)acetamide; 2-(4-{[7-(2-chloroethoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-yl- )-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-(4-([7-(2,2-dimethoxyethoxy)quinazolin-4-yl]amin- o)-1H-pyrazol-1-yl)acetamide; 4-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1-{2-[(3-fluoroph- enyl)amino]-2-oxoethyl}-1H-pyrazole-3-carboxamide; ethyl 4-{[7-(3-chloropropoxy)quinazolin-4-yl]amino}-1-{2-[(3-fluorophenyl)amino- ]-2-oxoethyl}-1H-pyrazole-3-carboxylate; 2-(3-(acetylamino)-4-{[7-(3-chloropropoxy)quinazolin-4-yl]amino}-1H-pyraz- ol-1-yl)-N-(3-fluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-[4-(quinazolin-4-ylamino)-1H-pyrazol-1-yl]acetam- ide; 2-(4-{[7-(3-chloropropoxy)-5-isopropoxyquinazolin-4-yl]amino}-1H-pyra- zol-1-yl)-N-(2,3-difluorophenyl)acetamide; 2-(4-{[7-(3-chloropropoxy)-5-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-y- l)-N-(2,3-difluorophenyl)acetamide; 2-(4-{[7-(3-chloropropoxy)-6-fluoroquinazolin-4-yl]amino}-1H-pyrazol-1-yl- )-N-(2,3-difluorophenyl)acetamide; 2-(4-{[7-(3-chloropropoxy)-6-fluoroquinazolin-4-yl]amino}-1H-pyrazol-1-yl- )-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy}-6-- methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-(4-{[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin- -4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(3-fluorophenyl)-2-(4-{[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoli- n-4-yl]amino}-1H-pyrazol-1-yl)acetamide; 2-[4-({7-[3-(diethylamino)propoxy]-6-methoxyquinazolin-4-yl}amino)-1H-pyr- azol-1-yl]-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-(4-{[6-methoxy-7-(3-piperazin-1-ylpropoxy)quinazolin- -4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(methyl)amino]propoxy}-6-- methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-[4-({7-[3-(cyclopropylamino)propoxy]-6-methoxyquinazolin-4-yl}amino)-1H- -pyrazol-1-yl]-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[[2-(dimethylamino)ethyl](methyl)amino]propoxy}-6-methoxyquin- azolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-[4-({6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]- quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-[4-({7-[3-(4-hydroxypiperidin-1-yl)propoxy]-6-methox- yquinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; 2-{4-[(7-{3-[bis(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl)a- mino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[ethyl(methyl)amino]propoxy}-6-methoxyquinazolin-4-yl)amino]-- 1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[[2-(dimethylamino)ethyl](ethyl)amino]propoxy}-6-methoxyquina- zolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[2-(2-hydroxyethyl)piperidin-1-yl]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)amino]propoxy}-6-methoxyquinazolin-4-yl)a- mino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperidin-1-yl]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(6-methoxy-7-{3-[methyl(prop-2-yn-1-yl)amino]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[allyl(methyl)amino]propoxy}-6-methoxyquinazolin-4-yl)amino]-- 1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[isobutyl(methyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-[4-({7-[3-(3-hydroxypiperidin-1-yl)propoxy]-6-methox- yquinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-(4-[(6-methoxy-7-{3-[methyl(propyl)amino]propoxy}qui- nazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)(propyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[[2-(diethylamino)ethyl](methyl)amino]propoxy}-6-methoxyquina- zolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[[2-(diethylamino)ethyl](ethyl)amino]propoxy}-6-methoxyquinaz- olin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-[4-({6-methoxy-7-[3-(4-methyl-1,4-diazepan-1-yl)prop- oxy]quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(isopropyl)amino]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[cyclopropyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(2-methoxyethyl)amino]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[cyclobutyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[(cyclobutylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyqu- inazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(prop-2-yn-1-yl)amino]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[allyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[(2,2-dimethylpropyl)(2-hydroxyethyl)amino]propoxy}-6-methoxy- quinazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(3,3,3-trifluoropropyl)am- ino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-(4-{[7-(3-azetidin-1-ylpropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyra- zol-1-yl)-N-(3-fluorophenyl)acetamide; 2-{4-[(6,7-dimethoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluoroph- enyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-hydroxy-6-methoxyquinazolin-4-yl)amino]-1H-py- razol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy- }-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(dimethylamino)propoxy]-6-methoxyquina- zolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-(4-{[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinaz- olin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-(4-{[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quina- zolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-(4-{[6-methoxy-7-(3-piperazin-1-ylpropoxy)quinaz- olin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(methyl)amino]propoxy- }-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide 2-[4-({7-[3-(cyclopropylamino)propoxy]-6-methoxyquinazolin-4-yl}amino)-1H- -pyrazol-1-yl]-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[[2-(dimethylamino)ethyl](methyl)amino- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({6-methoxy-7-[3-(4-methylpiperazin-1-yl)prop- oxy]quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(4-hydroxypiperidin-1-yl)propoxy]-6-me- thoxyquinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; 2-{4-[(7-{3-[bis(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl)a- mino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[ethyl(methyl)amino]propoxy}-6-methoxy- quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[[2-(dimethylamino)ethyl](ethyl)amino]- propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[2-(2-hydroxyethyl)piperidin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)amino]propoxy}-6-methoxyquinazolin-4-yl)a- mino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperidin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(6-methoxy-7-{3-[methyl(prop-2-yn-1-yl)amino- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[isobutyl(methyl)amino]propoxy}-6-meth- oxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(3-hydroxypiperidin-1-yl)propoxy]-6-me- thoxyquinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(6-methoxy-7-{3-[methyl(propyl)amino]propoxy- }quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)(propyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{3-[[2-(diethylamino)ethyl](methyl)amino]propoxy}-6-methoxyquina- zolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{3-[[2-(diethylamino)ethyl](ethyl)amino]propoxy}-6-methoxyquinaz- olin-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-[4-({6-methoxy-7-[3-(4-methyl-1,4-diazepan-1-yl)- propoxy]quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(isopropyl)amino]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[cyclopropyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(2-methoxyethyl)amino- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[cyclobutyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{3-[(cyclobutylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyqu- inazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(prop-2-yn-1-yl)amino- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[allyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2,2-dimethylpropyl)(2-hydroxyethyl)a- mino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(3,3,3-trifluoropropy- l)amino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide- ; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-y- l]ethoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(2-{4-[2-(2-hydroxyethoxy)ethyl]piperazin- -1-yl}ethoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[2-(hydroxymethyl)piperidin-1-yl]ethox- y}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2-hydroxy-1,1-dimethylethyl)amino]et- hoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[4-(2-hydroxyethyl)piperazin-1-yl]etho- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(trans-4-hydroxycyclohexyl)amino]etho- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[3-(hydroxymethyl)piperidin-1-yl]ethox- y}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(2-{[1-(hydroxymethyl)cyclopentyl]amino}e- thoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[4-(3-hydroxypropyl)piperazin-1-yl]eth- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{2-[cyclohexyl(2-hydroxyethyl)amino]ethoxy}-6-methoxyquinazolin-- 4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2-hydroxyethyl)(propyl)amino]ethoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(3-hydroxy-2,2-diethylpropyl)amino]et- hoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({6-methoxy-7-[2-(tetrahydro-2H-pyran-4-ylami- no)ethoxy]quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; 2-{4-[(7-{2-[cyclobutyl(2-hydroxyethyl)amino]ethoxy}-6-methoxyquinazolin-- 4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2-hydroxyethyl)(tetrahydro-2H-pyran-- 4-yl)amino]ethoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetami- de; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2S)-2-(hydroxymethyl)pyrrolidin-1- -yl]ethoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2R)-2-(2-hydroxyethyl)piperidin-1-yl- ]ethoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl- ]ethoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy- }quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propo- xy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[cyclopentyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)ami- no]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}qu- inazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]prop- oxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3-hydroxy-1,1-dimethylpropyl)amino]p- ropoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[(2-cyanoethyl)(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)- amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]- amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3-hydroxy-2,2-dimethylpropyl)amino]p- ropoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3-hydroxypropyl)amino]propoxy}quinaz- olin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3-hydroxypropyl)(propyl)amino]propox- y}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[ethyl(3-hydroxypropyl)amino]propoxy}q- uinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)-3-oxopiperazin-1-y- l]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(propylamino)propoxy]quinazolin-4-yl}a- mino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-piperazin-1-ylpropoxy)quinazolin-4-yl]- amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[glycoloyl(propyl)amino]propoxy}quinaz- olin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(4-glycoloylpiperazin-1-yl)propoxy]qui- nazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-{[trans-2-(hydroxymethyl)cyclohexyl]am- ino}propoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(1.alpha., 5.alpha., 6.alpha.)-6-(hydroxymethyl)-3-azabicyclo[3.1.0]hex-3-yl]propoxy}quinazoli- n-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-{[(2R)-2-hydroxypropyl]amino}propoxy)q- uinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-{[(1S)-2-hydroxy-1-methylethyl]amino}p- ropoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxy-1,1-dimethylethyl)amino]pr- opoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2,3-dihydroxypropyl)amino]propoxy}qu- inazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-{[2-(2-hydroxyethoxy)ethyl]amino}propo- xy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; 2-[4-({7-[3-(4-acetylpiperazin-1-yl)propoxy]quinazolin-4-yl}amino)-1H-pyr- azol-1-yl]-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(tetrahydrofuran-2-ylmethyl)amino]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-[4-({7-[3-(allylamino)propoxy]quinazolin-4-yl}amino)-1H-pyrazol-1-yl]-N- -(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-{[1-(hydroxymethyl)-2-methylpropyl]ami- no}propoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-{[(5-methylisoxazol-3-yl)methyl]amino}- propoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(tetrahydro-2H-pyran-4-ylamino)propoxy- ]quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3S)-3-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-hydroxypropoxy)quinazolin-4-yl]amino}-- 1H-pyrazol-1-yl)acetamide; 2-(4-{[7-(3-aminopropoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(2,3-d- ifluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2S,4R)-4-hydroxy-2-(hydroxymethyl)py- rrolidin-1-yl]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(3-hydroxy-2,2-dimethylpropyl)amino]e- thoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{2-[cyclohexyl(2-hydroxyethyl)amino]ethoxy}quinazolin-4-yl)amino- ]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-[4-({7-[2-(cyclopropylamino)ethoxy]quinazolin-4-yl}amino)-1H-pyrazol-1-- yl]-N-(2,3-difluorophenyl)acetamide; 2-[4-({7-[2-(cyclobutylamino)ethoxy]quinazolin-4-yl}amino)-1H-pyrazol-1-y- l]-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[2-(tetrahydro-2H-pyran-4-ylamino)ethoxy]- quinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; 2-[4-({7-[2-(cyclopentylamino)ethoxy]quinazolin-4-yl}amino)-1H-pyrazol-1-- yl]-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2-hydroxyethyl)(tetrahydro-2H-pyran-- 4-yl)amino]ethoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{2-[cyclopentyl(2-hydroxyethyl)amino]ethoxy}quinazolin-4-yl)amin- o]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]ethoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{2-[cyclopropyl(2-hydroxyethyl)amino]ethoxy}quinazolin-4-yl)amin- o]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{2-[cyclobutyl(2-hydroxyethyl)amino]ethoxy}quinazolin-4-yl)amino- ]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{2-[cyclopentyl(3-hydroxypropyl)amino]ethoxy}quinazolin-4-yl)ami- no]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{2-[cyclopentyl(glycoloyl)amino]ethoxy}quinazolin-4-yl)amino]-1H- -pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(3S)-3-(hydroxymethyl)-4-methylpipera- zin-1-yl]ethoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]ethoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2R)-2-(hydroxymethyl)-4-methylpipera- zin-1-yl]ethoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[4-(hydroxymethyl)piperidin-1-yl]ethox- y}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[4-(2-hydroxyethyl)piperidin-1-yl]etho- xy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{2-[(2-hydroxyethyl)amino]ethoxy}quinazol- in-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(2-{[trans-2-(hydroxymethyl)cyclohexyl]am- ino}ethoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)amino]propoxy}quinazo- lin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl- ]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-methoxyquinazolin-4-yl)amino]-1H-pyrazol-- 1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(tetrahydro-2H-pyran-- 4-yl)amino]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(2-hydroxyethyl)piperidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)-4-methylpipera- zin-1-yl]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3S)-3-(hydroxymethyl)-4-methylpipera- zin-1-yl]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)morpholin-4-yl]- propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(3S)-3-(hydroxymethyl)morpholin-4-yl]- propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(glycoloylamino)propoxy]quinazolin-4-y- l}amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy}qui- nazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)amino]-1H- -pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}q- uinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(3-hydroxy-1,1-dimethylpropyl)amino]propo- xy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[2-(2-hydroxyethyl)piperidin-1-yl]propoxy}- quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propoxy}- quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(tetrahydrofuran-3-yl)ami- no]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-(4-{[7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amin- o}-1H-pyrazol-1-yl)acetamide; N-(3-fluorophenyl)-2-[4-({7-[(2S)-pyrrolidin-2-ylmethoxy]quinazolin-4-yl}- amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-{4-[(7-{[(2S)-1-(2-hydroxyethyl)pyrrolidin-2-yl]meth- oxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-{[(2S)-1-glycoloylpyrrolidin-2-yl]methoxy}qui- nazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-(4-{[7-(pyrrolidin-3-ylmethoxy)quinazolin-4-yl]amino- }-1H-pyrazol-1-yl)acetamide; N-(3-fluorophenyl)-2-{4-[(7-{[1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy}q- uinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-[4-({7-[(1-glycoloylpyrrolidin-3-yl)methoxy]quinazol- in-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)(2-methoxyethyl)amino]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(3-fluorophenyl)-2-{4-[(7-hydroxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl- }acetamide; N-(2-fluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide 2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)amino]-1H- -pyrazol-1-yl}-N-(2-fluorophenyl)acetamide; 2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]propoxy}quinazolin-4-y- l)amino]-1H-pyrazol-1-yl}-N-phenylacetamide; 2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)amino]-1H- -pyrazol-1-yl)-N-phenylacetamide; N-(2,6-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6-fluoroquinazolin-4-yl)- amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; 2-{4-[(7-{3-[(cyclopropylmethyl)(2-hydroxyethyl)amino]propoxy}-6-fluoroqu- inazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(6-fluoro-7-{3-[(2-hydroxyethyl)(propyl)amin- o]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(6-fluoro-7-{3-[(2R)-2-(hydroxymethyl)pyrrol- idin-1-yl]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; 2-{4-[(7-{3-[cyclopentyl(2-hydroxyethyl)amino]propoxy}-6-fluoroquinazolin- -4-yl)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; 2-{4-[(7-{3-[bis(2-hydroxyethyl)amino]propoxy}-5-isopropoxyquinazolin-4-y- l)amino]-1H-pyrazol-1-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-5-isopropoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]prop- oxy}-5-isopropoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-(4-{[5-isopropoxy-7-(3-piperazin-1-ylpropoxy)qui- nazolin-4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-5-isopropoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2-hydroxyethyl)amino]propoxy}-5-isop- ropoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-[3-(4-glycoloylpiperazin-1-yl)propoxy]-5-- isopropoxyquinazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-{4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-5-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(5,7-dimethoxyquinazolin-4-yl)amino]-1H-pyra- zol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(5-hydroxy-7-methoxyquinazolin-4-yl)amino]-1- H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-[4-({7-methoxy-5-[(2R)-pyrrolidin-2-ylmethoxy]qu- inazolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(2,3-difluorophenyl)-2-{4-[(5-{[(2R)-1-glycoloylpyrrolidin-2-yl]methoxy- }-7-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl)acetamide; N-(2,3-difluorophenyl)-2-{4-[(5-{[(2R)-1-(N,N-dimethylglycyl)pyrrolidin-2- -yl]methoxy}-7-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(5-{[(2R)-1-(2-hydroxyethyl)pyrrolidin-2-yl]- methoxy}-7-methoxyquinazolin-4-yl)amino]-1H-pyrazol-1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(5-methoxyquinazolin-4-yl)amino]-1H-pyrazol-- 1-yl}acetamide; N-(2,3-difluorophenyl)-2-{4-[(5-fluoroquinazolin-4-yl)amino]-1H-pyrazol-1- -yl}acetamide; N-(3-fluorophenyl)-2-(4-{[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin- -4-yl]amino}-1H-pyrazol-1-yl)acetamide; N-(3-fluorophenyl)-2-[4-({7-methoxy-6-[(1-methylpyrrolidin-3-yl)oxy]quina- zolin-4-yl}amino)-1H-pyrazol-1-yl]acetamide; N-(3-fluorophenyl)-2-(4-{[7-methoxy-6-(2-morpholin-4-ylethoxy)quinazolin-- 4-yl]amino}-1H-pyrazol-1-yl)acetamide; 2-(4-{[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-- (2,3-difluorophenyl)acetamide; N-(3-fluorophenyl)-2-{4-[(6-hydroxy-7-methoxyquinazolin-4-yl)amino]-1H-py- razol-1-yl}acetamide; 4-((1-(2-((2,3-difluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-4-yl)amino)-7- -((1-methylpiperidin-4-yl)methoxy)quinazolin-6-yl benzoate; N-(2,3-difluorophenyl)-2-(4-((6-hydroxy-7-((1-methylpiperidin-4-yl)methox- y)quinazolin-4-yl)amino)-1H-pyrazol-1-yl)acetamide; 1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-4-[(7-{3-[(2-hydroxyethyl)(2-met- hoxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazole-3-car- boxamide; 1-{2-[(3-fluorophenyl)amino]-2-oxoethyl-4-[(7-{3-[(2S)-2-(hydrox- ymethyl)pyrrolidin-1-yl]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazo- le-3-carboxamide; 2-{3-(acetylamino)-4-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]propox- y}quinazolin-4-yl)amino]-1H-pyrazol-1-yl}-N-(3-fluorophenyl)acetamide; ethyl 1-{2-[(3-fluorophenyl)amino]-2-oxoethyl)-4-[(7-{3-[(2R)-2-(hydroxym- ethyl)pyrrolidin-1-yl]propoxy}quinazolin-4-yl)amino]-1H-pyrazole-3-carboxy- late; and 1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-4-[(7-3-[(2R)-2-(hydrox- ymethyl)pyrrolidin-1-yl]propoxy}quinazolin-4-yl)amino]-1H-pyrazole-3-carbo- xylic acid; or a salt, ester or prodrug thereof. 17. A compound of formula (IA) selected from: 2-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]-6-methoxyquinazolin-7-yl}oxy)propyl](propyl)amino]ethyl dihydrogen phosphate; {(2S)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]-6-methoxyquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; {(2S)-1-[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl- )amino]-6-methoxyquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; 2-{ethyl[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl- )amino]-6-methoxyquinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl- )amino]-6-methoxyquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl)methyl dihydrogen phosphate; 2-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]-6-methoxyquinazolin-7-yl}oxy)propyl](2-methoxyethyl)amino]ethyl dihydrogen phosphate; {(2S)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]quinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl)methyl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl)-1H-pyrazol-- 4-yl)amino]quinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl)methyl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]-6-methoxyquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; 2-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]-6-methoxyquinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate; 2-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl](propyl)amino]ethyl dihydrogen phosphate; 2-{cyclobutyl[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyr- azol-4-yl)amino]-6-methoxyquinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; 2-{cyclobutyl[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol- -4-yl)amino]-6-methoxyquinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; 2-[[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)amin- o]-6-methoxyquinazolin-7-yl}oxy)propyl](2-methoxyethyl)amino]ethyl dihydrogen phosphate; 2-[[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)amin- o]quinazolin-7-yl}oxy)propyl](propyl)amino]ethyl dihydrogen phosphate; 2-{4-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-y- l)amino]quinazolin-7-yl}oxy)propyl]piperazin-1-yl}ethyl dihydrogen phosphate; 2-{ethyl[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl- )amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; 2-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate; 3-{[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)amin- o]quinazolin-7-yl}oxy)propyl]amino}-3-methylbutyl dihydrogen phosphate; 3-{[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl]amino}-3-methylbutyl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl- )amino]quinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; 2-{4-[3-({4-[(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)am- ino]quinazolin-7-yl}oxy)propyl]piperazin-1-yl}ethyl dihydrogen phosphate 3-{[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl]amino}propyl dihydrogen phosphate; 2-{[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; 2-[[3-((4-[(1-{.sup.2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl- )amino]quinazolin-7-yl}oxy)propyl](2-methoxyethyl)amino]ethyl dihydrogen phosphate; 3-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl](ethyl)amino]propyl dihydrogen phosphate; 3-[[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)propyl](propyl)amino]propyl dihydrogen phosphate; 2-[[3-({4-[(1-{.sup.2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]quinazolin-7-yl}oxy)propyl](propyl)amino]-2-oxoethyl dihydrogen phosphate; 2-{4-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-y- l)amino]quinazolin-7-yl}oxy)propyl]piperazin-1-yl}-2-oxoethyl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]-6-fluoroquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; 4-((1-(2-((2,3-difluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-4-yl)amino)-7- -((1-methylpiperidin-4-yl)methoxy)quinazolin-6-yl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl)-1H-pyrazol-- 4-yl)amino]-5-isopropoxyquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; 2-{4-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-y- l)amino]-5-isopropoxyquinazolin-7-yl)oxy)propyl]piperazin-1-yl}ethyl dihydrogen phosphate; 2-{[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl)-1H-pyrazol-4-yl)- amino]-5-isopropoxyquinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; {(2R)-1-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]-5-methoxyquinazolin-7-yl}oxy)propyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; {(2R)-1-[2-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]-6-methoxyquinazolin-7-yl}oxy)ethyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; {(2S)-1-[2-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-- 4-yl)amino]-6-methoxyquinazolin-7-yl)oxy)ethyl]pyrrolidin-2-yl}methyl dihydrogen phosphate; 2-[[2-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl)-1H-pyrazol-4-yl)- amino]-6-methoxyquinazolin-7-yl}oxy)ethyl](tetrahydro-2H-pyran-4-yl)amino]- ethyl dihydrogen phosphate; 2-{4-[3-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-y- l)amino]quinazolin-7-yl}oxy)propyl]-2-oxopiperazin-1-yl}ethyl dihydrogen phosphate; and 2-[[2-({4-[(1-{2-[(2,3-difluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-4-yl)- amino]quinazolin-7-yl}oxy)ethyl](tetrahydro-2H-pyran-4-yl)amino]ethyl dihydrogen phosphate; or a salt or ester thereof. 18. A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt or ester thereof, in association with a pharmaceutically acceptable diluent or carrier. 19. A process for the preparation of a compound according to claim 1 or a pharmaceutically acceptable salt or ester thereof, which process comprises reacting a compound of formula (II) ##STR00063## where L is a suitable leaving group and R.sup.1, R.sup.2, R.sup.3, R.sup.4 are as defined in claim 1 with a compound of formula (III) ##STR00064## wherein R.sup.5 and R.sup.19 are as defined in claim 1 in the presence of hydrochloric acid in dioxane under an inert atmosphere, and thereafter if necessary: i) removing any protecting groups; and/or ii) forming a salt, ester or prodrug thereof. 20. A process for the preparation of a compound according to formula (IA) or a pharmaceutically acceptable salt thereof, which process comprises phosphorylation of a compound of formula (I) ##STR00065## or a salt or ester thereof; where X is O or NR.sup.6; R.sup.6 is hydrogen or C.sub.1-4alkyl; R.sup.1 is hydrogen, halo, or --X.sup.1R.sup.11; X.sup.1 is a direct bond, --CH.sub.2.dbd.CH.sub.2--, --O--, --NH--, --N(C.sub.1-6alkyl)-, --C(O)O--, --C(O)O--, --OC(O)O--, --NHC(O)--, --N(C.sub.1-6alkyl)C(O)--, --C(O)NH-- or --C(O)N(C.sub.1-6alkyl)-; R.sup.11 is hydrogen, or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by 1 or 2 substituents independently selected from halo, hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, --NR.sup.9R.sup.10, --C(O)R.sup.9, --C(O)NR.sup.9R.sup.10 and --C(O)OR.sup.9; R.sup.2 is hydrogen, halo, nitro, cyano or --X.sup.2R.sup.12; X.sup.2 is a direct bond, --O--, --NH--, --N(C.sub.1-6alkyl)-, --OC(O)-- or --C(O)O--; R.sup.12 is hydrogen, or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl, which group is optionally substituted by 1, 2 or 3 substituents selected from halo, hydroxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, --NR.sup.15R.sup.16, --NHC(O)NR.sup.15R.sup.16, --C(O)R.sup.15 and --C(O)OR.sup.15; R.sup.3 is hydrogen, halo or --X.sup.3R.sup.13; X.sup.3 is a direct bond, --CH.sub.2.dbd.CH.sub.2--, --O--, --NH--,--N(C.sub.1-6alkyl)-, --C(O)--, --C(O)O--, --OC(O)--, --NHC(O)O--, --N(C.sub.1-6alkyl)C(O)--, --C(O)NH-- or --C(O)N(C.sub.1-6alkyl)-; R.sup.13 is hydrogen or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by 1 or 2 substituents independently selected from --NR.sup.7R.sup.8, --C(O)NR.sup.7R.sup.8, halo, hydroxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; R.sup.7 and R.sup.8 are independently selected from hydrogen, heterocyclyl, heterocyclylC.sub.1-4alkyl, C.sub.1-4alkylheterocyclylC.sub.1-4alkyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, C.sub.1-4alkoxyC.sub.1-6alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.3-6cycloalkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkyl, hydroxyC.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkylC.sub.1-4alkyl, haloC.sub.1-6alkyl, haloC.sub.3-6cycloalkyl, haloC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, cyanoC.sub.1-4alkyl, aminoC.sub.1-6alkyl, C.sub.1-4alkylaminoC.sub.1-6alkyl, bis(C.sub.1-4alkyl)aminoC.sub.1-6alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; or R.sup.7 and R.sup.8 together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of which one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; R.sup.4 is selected from hydrogen, halo or --X.sup.4R.sup.14; X.sup.4 is a direct bond, --O--, --NH-- or --N(C.sub.1-6alkyl)-; R.sup.14 is selected from hydrogen, C.sub.1-6alkyl, C.sub.2-6alkenyl and C.sub.2-6alkynyl; R.sup.5 is aryl or heteroaryl optionally substituted by 1, 2 or 3 substituents independently selected from halo, hydroxy, cyano, nitro, amino, C.sub.1-4alkylamino, bis(C.sub.1-4alkyl)amino, C.sub.1-4alkyl, C.sub.2-4alkenyl, C.sub.2-4alkynyl, C.sub.1-4alkoxy, --CONHR.sup.17, --NHCOR.sup.18--SR.sup.17, --S(O)R.sup.17 and --S(O)OR.sup.17; R.sup.9, R.sup.10, R.sup.15 and R.sup.16 are independently selected from hydrogen, C.sub.1-6alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.1-6alkyl, haloC.sub.1-6alkyl, aminoC.sub.1-6alkyl, C.sub.1-4alkylaminoC.sub.1-6alkyl and bis(C.sub.1-4alkyl)aminoC.sub.1-6alkyl; or R.sup.9 and R.sup.10 together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of which one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; R.sup.17 and R.sup.18 are independently selected from hydrogen, C.sub.1-4alkyl, C.sub.3-6cycloalkyl, C.sub.2-4alkenyl and C.sub.2-4alkynyl; R.sup.19 is hydrogen, hydroxyC.sub.1-4alkyl, --C(O)R.sup.20, --C(O)OR.sup.20, --CONR.sup.20R.sup.21, --NHC(O)R.sup.20 or --NHC(O)OR.sup.20; R.sup.20 are R.sup.21 are independently selected from hydrogen, C.sub.1-4alkyl and aryl followed by deprotection of the phosphate group to yield a compound of formula (IA) ##STR00066## or salt or ester thereof where X, X.sup.1, X.sup.2, X.sup.3, R.sup.4, R.sup.5 and R.sup.19 are as defined in relation to formula (I) and R.sup.1' is hydrogen, halo, or --X.sup.1R.sup.11'; R.sup.11' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by a substituent selected from halo, hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, --NR.sup.9'R.sup.10', --C(O)R.sup.9', --C(O)NR.sup.9'R.sup.10' and --C(O)OR.sup.9'; R.sup.2' is hydrogen, halo, nitro, cyano or --X.sup.2R.sup.12'; R.sup.12' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl, which group is optionally substituted by 1, 2 or 3 substituents selected from halo, hydroxy, phosphonooxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, --NR.sup.15'R.sup.16', --NHC(O)NR.sup.15'R.sup.16'--, --C(O)R.sup.15'-- and --C(O)OR.sup.15'--; R.sup.3' is hydrogen, halo or --X.sup.3R.sup.13'; R.sup.13' is hydrogen, phosphonooxy or a group selected from C.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, aryl, arylC.sub.1-4alkyl, arylC.sub.2-4alkenyl, arylC.sub.2-4alkynyl, heterocyclyl, heterocyclylC.sub.1-4alkyl, heterocyclylC.sub.2-4alkenyl and heterocyclylC.sub.2-4alkynyl which group is optionally substituted by 1 or 2 substituents independently selected from --NR.sup.7'R.sup.8', --C(O)NR.sup.7'R.sup.8', halo, hydroxy, phosphonooxy, C.sub.1-4alkyl, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosponooxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; R.sup.7' and R.sup.8' are independently selected from hydrogen, heterocyclyl, heterocyclylC.sub.1-4alkyl, C.sub.1-4alkylheterocyclylC.sub.1-4alkyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, phosphonooxyC.sub.1-6alkyl, C.sub.1-4alkoxyC.sub.1-6alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.3-6cycloalkyl, phosphonooxyC.sub.3-6cycloalkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkyl, phosphonooxyC.sub.1-4alkylC.sub.3-6cycloalkyl, hydroxyC.sub.3-6cycloalkylC.sub.1-4alkyl, phosphonooxyC.sub.3-6cycloalkylC.sub.1-4alkyl, hydroxyC.sub.1-4alkylC.sub.3-6cycloalkylC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkylC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkyl, C.sub.1-4alkoxyC.sub.3-6cycloalkylC.sub.1-4alkyl, haloC.sub.1-6alkyl, haloC.sub.3-6cycloalkyl, haloC.sub.3-6cycloalkylC.sub.1-4alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, cyanoC.sub.1-4alkyl, aminoC.sub.1-6alkyl, C.sub.1-4alkylaminoC.sub.1-6alkyl, bis(C.sub.1-4alkyl)aminoC.sub.1-6alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl; or R.sup.7' and R.sup.8' together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; R.sup.9', R.sup.10', R.sup.15' and R.sup.16' are independently selected from hydrogen, C.sub.1-alkyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkylC.sub.1-3alkyl, hydroxyC.sub.1-6alkyl, phosphonooxyC.sub.1-6alkyl, haloC.sub.1-6alkyl, aminoC.sub.1-6alkyl, C.sub.1-6alkylaminoC.sub.1-6alkyl and bis(C.sub.1-6alkyl)aminoC.sub.1-6alkyl; or R.sup.9' and R.sup.10' together with the nitrogen to which they are attached form a heterocyclic ring which ring is monocyclic or bicyclic and comprises 4 to 7 ring atoms of which one is nitrogen and of which another is optionally selected from N, NH, O, S, SO and SO.sub.2, and which ring is optionally substituted on carbon or nitrogen by 1 or 2 substituents independently selected from C.sub.1-4alkyl, hydroxy, phosphonooxy, C.sub.1-4alkoxy, hydroxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkyl, hydroxyC.sub.1-4alkoxyC.sub.1-4alkyl, phosphonooxyC.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkoxyC.sub.1-4alkoxy, hydroxyC.sub.1-4alkylcarbonyl, phosphonooxyC.sub.1-4alkylcarbonyl, C.sub.1-4alkylcarbonyl, aminoC.sub.1-4alkylcarbonyl, C.sub.1-4alkylaminoC.sub.1-4alkylcarbonyl and bis(C.sub.1-4alkyl)aminoC.sub.1-4alkylcarbonyl, and where a ring --CH.sub.2-- is optionally replaced with --C(O)--; provided that a compound of formula (IA) contains at least one phosphonooxy group. 21. A method of treating a human suffering from colorectal cancer, comprising the steps of administering to a person in need thereof a therapeutically effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt or ester thereof. 